SLC10A1 variants causing NTCP deficiency in infants: clinical and functional characterization of a novel splice-site variant
- 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Abstract
Background: Sodium taurocholate cotransporting polypeptide (NTCP), the product of the SLC10A1 gene, is essential for hepatic bile acid (BA) uptake. Biallelic SLC10A1 defects resulting in NTCP deficiency have recently been identified as a cause of familial hypercholanemia in children, but clinical and functional data are lacking.
Methods: Three unrelated infants with neonatal or infantile cholestasis were recruited. Clinical data, laboratory results, and follow-up details were reviewed. SLC10A1 variants were identified by whole-exome sequencing (WES) and confirmed by Sanger sequencing. An HEK293T minigene splicing assay was used to assess the functional consequences of the new splicing variant.
Results: All three patients exhibited sustained hypercholanemia accompanied by varying degrees of elevated liver enzymes and decreased levels of fat-soluble vitamins. WES identified homozygous or compound heterozygous SLC10A1 variants in all three patients, including the frequent East Asian missense variant c.800 C > T (p.Ser267Phe), the rare frameshift variant c.722_723del (p.Ser241Cysfs*36), and a novel splice-site variant c.746 + 5G > T. The c.746 + 5G > T variant was predicted to affect splicing, and a minigene assay showed that this variant caused exon 3 skipping, which is predicted to result in a frameshift transcript. According to ACMG/AMP guidelines, c.722_723del variant was classified as “Pathogenic”, and the c.746 + 5G > T variant was assessed as “Pathogenic” after incorporating functional evidence from the minigene assay.
Conclusions: This study broadens the variant spectrum of SLC10A1-related NTCP deficiency and highlights the value of functional testing in the assessment of novel splicing-site variants. Early genetic diagnosis may facilitate appropriate clinical management and help prevent unnecessary interventions.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07411-3.
Related
- Fructose-1,6-bisphosphatase deficiency: the clinical characteristics, molecular consequences of FBP1 variants, and emerging non-canonical functions of FBP1
- Endocannabinoid System Genes in Dementia: A Systematic Mendelian Randomization Study of Functional Variants and Tissue-Specific Expression Across Clinical, Molecular, and Neuroimaging Phenotypes
- Diagnostic Yield of Expanded Multigene Testing in Hereditary Polyposis Syndromes: Functional Characterization of Clinically Relevant Variants
- Deciphering the molecular impact of ALDH5A1 missense variants in succinic semialdehyde dehydrogenase deficiency through combined in vitro and in silico approaches
- Concealed right upper lobe pulmonary venous variants on 3D-CTBA: morphological characterization and surgical implications
BibTeX
@article{cheng2026slc10a1,
title = {{SLC10A1 variants causing NTCP deficiency in infants: clinical and functional characterization of a novel splice-site variant}},
author = {Wenzhuo Cheng and Fan Chen and Wen Pan and Biao Zou and Sainan Shu},
journal = {BMC Pediatrics},
year = {2026},
month = jul,
doi = {10.1186/s12887-026-07411-3},
url = {https://doi.org/10.1186/s12887-026-07411-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - SLC10A1 variants causing NTCP deficiency in infants: clinical and functional characterization of a novel splice-site variant
AU - Wenzhuo Cheng
AU - Fan Chen
AU - Wen Pan
AU - Biao Zou
AU - Sainan Shu
PY - 2026
DA - 2026/07/30
JO - BMC Pediatrics
DO - 10.1186/s12887-026-07411-3
UR - https://doi.org/10.1186/s12887-026-07411-3
AB - Background: Sodium taurocholate cotransporting polypeptide (NTCP), the product of the SLC10A1 gene, is essential for hepatic bile acid (BA) uptake. Biallelic SLC10A1 defects resulting in NTCP deficiency have recently been identified as a cause of familial hypercholanemia in children, but clinical and functional data are lacking. Methods: Three unrelated infants with neonatal or infantile cholestasis were recruited. Clinical data, laboratory results, and follow-up details were reviewed. SLC10A1 variants were identified by whole-exome sequencing (WES) and confirmed by Sanger sequencing. An HEK293T minigene splicing assay was used to assess the functional consequences of the new splicing variant. Results: All three patients exhibited sustained hypercholanemia accompanied by varying degrees of elevated liver enzymes and decreased levels of fat-soluble vitamins. WES identified homozygous or compound heterozygous SLC10A1 variants in all three patients, including the frequent East Asian missense variant c.800 C > T (p.Ser267Phe), the rare frameshift variant c.722_723del (p.Ser241Cysfs*36), and a novel splice-site variant c.746 + 5G > T. The c.746 + 5G > T variant was predicted to affect splicing, and a minigene assay showed that this variant caused exon 3 skipping, which is predicted to result in a frameshift transcript. According to ACMG/AMP guidelines, c.722_723del variant was classified as “Pathogenic”, and the c.746 + 5G > T variant was assessed as “Pathogenic” after incorporating functional evidence from the minigene assay. Conclusions: This study broadens the variant spectrum of SLC10A1-related NTCP deficiency and highlights the value of functional testing in the assessment of novel splicing-site variants. Early genetic diagnosis may facilitate appropriate clinical management and help prevent unnecessary interventions. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07411-3.
SN - 1471-2431
ER -